Search

Author/Creator Arkin, S.

1. A first‐in‐human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of PF‐06741086, an anti‐tissue factor pathway inhibitor mAb, in healthy volunteers. (20th July 2018)

Authors:
Cardinal, M.; Kantaridis, C.; Zhu, T.; Sun, P.; Pittman, D. D.; Murphy, J. E.; Arkin, S.
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 16:Number 9(2018)
Page Start:
1722
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase 1, single‐dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia. (27th August 2018)

Authors:
Gruppo, R. A.; Malan, D.; Kapocsi, J.; Nemes, L.; Hay, C. R. M.; Boggio, L.; Chowdary, P.; Tagariello, G.; von Drygalski, A.; Hua, F.; Scaramozza, M.; Arkin, S.
Other Names:
Hermans C. R. J. R. investigator.; Claes C. investigator.; Hanes I. investigator.; Huyghe I. investigator.; Kantaridis C. investigator.; da Costa L. M. investigator.; Ndongo M.‐N. investigator.; Petit W. investigator.; Santagostino E. M. investigator.; Cannavo A. investigator.; Fasulo M. R. inves...
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 16:Number 10(2018)
Page Start:
1984
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗